Washington Trust Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200	Closed	-$13K	–	946
2022 Q1	$13K	Hold	200	–	–	﹤0.01%	667
2021 Q4	$15K	Buy	+200	New	+$15K	﹤0.01%	672